Literature DB >> 2904292

Hypomethylation of ornithine decarboxylase gene and erb-A1 oncogene in human chronic lymphatic leukemia.

V Lipsanen1, P Leinonen, L Alhonen, J Jänne.   

Abstract

The methylation state of CCGG sites in and around the human ornithine decarboxylase gene, oncogenes c-myc and erb-A1, and actin genes were determined in human malignant leucocytes from patients with acute and chronic myeloid leukemia, chronic lymphatic leukemia, polycythemia vera, and multiple myeloma by means of isoschizomeric restriction endonuclease analysis. When compared with DNA from leucocytes of healthy controls, the ornithine decarboxylase and erb-A1 genes were substantially hypomethylated in all samples obtained from patients with chronic lymphatic leukemia. Hypomethylation of genes, particularly growth-related sequences, might be a crucial fact in the malignant transformation of human leucocytes. Its relatively simple detection from blood samples may prove clinically applicable in monitoring patients with chronic lymphatic leukemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904292

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Uncovering the DNA methylome in chronic lymphocytic leukemia.

Authors:  Nicola Cahill; Richard Rosenquist
Journal:  Epigenetics       Date:  2013-01-15       Impact factor: 4.528

2.  DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancer.

Authors:  Alain G Zeimet; Heidi Fiegl; Georg Goebel; Francis Kopp; Claude Allasia; Daniel Reimer; Ilona Steppan; Elisabeth Mueller-Holzner; Melanie Ehrlich; Christian Marth
Journal:  Gynecol Oncol       Date:  2011-01-20       Impact factor: 5.482

3.  Certain changes in ornithine decarboxylase gene methylation accompany gene amplification.

Authors:  J Wahlfors
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

4.  Large-scale analysis of DNA methylation in chronic lymphocytic leukemia.

Authors:  Farahnaz B Rahmatpanah; Stephanie Carstens; Sam I Hooshmand; Elise C Welsh; Ozy Sjahputera; Kristen H Taylor; Lynda B Bennett; Huidong Shi; J Wade Davis; Gerald L Arthur; Tait D Shanafelt; Neil E Kay; James E Wooldridge; Charles W Caldwell
Journal:  Epigenomics       Date:  2009-10       Impact factor: 4.778

5.  Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer.

Authors:  Erika M Wolff; Hyang-Min Byun; Han F Han; Shikhar Sharma; Peter W Nichols; Kimberly D Siegmund; Allen S Yang; Peter A Jones; Gangning Liang
Journal:  PLoS Genet       Date:  2010-04-22       Impact factor: 5.917

6.  Patterns of methylation of the c-myc gene in human colorectal cancer progression.

Authors:  R M Sharrard; J A Royds; S Rogers; A J Shorthouse
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640

7.  Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis.

Authors:  P Cheng; C Schmutte; K F Cofer; J C Felix; M C Yu; L Dubeau
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  RUNX3 has an oncogenic role in head and neck cancer.

Authors:  Takaaki Tsunematsu; Yasusei Kudo; Shinji Iizuka; Ikuko Ogawa; Tsuyoshi Fujita; Hidemi Kurihara; Yoshimitsu Abiko; Takashi Takata
Journal:  PLoS One       Date:  2009-06-12       Impact factor: 3.240

9.  Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.

Authors:  Garima Kushwaha; Mikhail Dozmorov; Jonathan D Wren; Jing Qiu; Huidong Shi; Dong Xu
Journal:  Hum Genomics       Date:  2016-07-25       Impact factor: 4.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.